|
Phenotype
|
Fish
|
Conditions
|
Figures
|
|
pectoral fin development disrupted, abnormal
|
AB/TL + MO3-shox
|
standard conditions
|
Fig. S3
from Montalbano et al., 2016
|
|
pectoral fin decreased size, abnormal
|
AB/TL + MO3-shox
|
standard conditions
|
Fig. S3
from Montalbano et al., 2016
|
|
whole organism decreased length, abnormal
|
AB/TU + MO3-shox
|
chemical treatment by environment: C-Type natriuretic peptide
|
Figure 3
from Hoffmann et al., 2026
|
|
whole organism decreased length, abnormal
|
AB/TU + MO3-shox
|
control
|
Figure 3
from Hoffmann et al., 2026
|
|
fin rasd1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
whole organism her15.1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin bmp4 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
whole organism shox2 expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
heart sox8a expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
whole organism cyp26c1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
head cdkn1a expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin nppa expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin vgf expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin shox2 expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin cdkn1a expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin sox18 expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin sox6 expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin cdkn1ca expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
whole organism rasd1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin her15.1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
heart cdkn1a expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
whole organism cdkn1a expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin krt17 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
head cyp26c1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin nppc expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin cyp26c1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin cyp26b1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin sox5 expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
heart cyp26c1 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
heart bmp4 expression increased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
fin sox8a expression decreased amount, abnormal
|
f1Tg + MO2-shox + MO3-shox
|
standard conditions
|
Fig. 2
from Hoffmann et al., 2021
|
|
whole organism nppa expression increased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
whole organism shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
head shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
heart nppa expression increased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
pectoral fin shox expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
whole organism shox expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
pectoral fin shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
pectoral fin nppc expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
heart shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
heart shox expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
head shox expression decreased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
heart nppb expression increased amount, abnormal
|
f1Tg + MO3-shox (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
whole organism nppa expression increased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
pectoral fin fgfr3 expression increased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 3
from Hoffmann et al., 2026
|
|
head shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
whole organism shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
pectoral fin nppb expression increased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
whole organism shox expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
whole organism fgfr3 expression increased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 3
from Hoffmann et al., 2026
|
|
pectoral fin nppc expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
pectoral fin shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
heart shox2 expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
head shox expression decreased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 1
from Hoffmann et al., 2026
|
|
heart nppb expression increased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|
|
whole organism nppb expression increased amount, abnormal
|
f1Tg + MO3-shox + MO3-shox2 (AB/TU)
|
control
|
Figure 2
from Hoffmann et al., 2026
|